Schabacker Matthew 4
4 · CONMED Corp · Filed Mar 4, 2026
Insider Transaction Report
Form 4
CONMED CorpCNMD
Schabacker Matthew
VP GM Advanced Surgical
Transactions
- Award
RSUs (Restricted Stock Units)
[F1]2026-03-02+9,827→ 9,827 totalExercise: $0.00Exp: 2036-03-02→ Common Stock (9,827 underlying) - Award
Options To Purchase Common Stock
[F2]2026-03-02+11,646→ 11,646 totalExercise: $45.79Exp: 2036-03-02→ Common Stock (11,646 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.
- [F2]The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.
Signature
/s/ Thomas Fistek for Matthew Schabacker by Power of Attorney|2026-03-04